Still feeling hungry on tirzepatide? Here's what's actually going on

You're two weeks in, expecting silence from your stomach, and it isn't there

This is the scenario our prescribers hear about most often, and it catches a lot of people off guard. The expectation tends to be total appetite suppression from the first pen. The reality is more gradual. Tirzepatide activates both GIP and GLP-1 receptors, slowing how quickly food leaves your stomach and signalling fullness to the brain, but those signals build across weeks rather than arriving all at once. At 2.5mg (the starting dose, designed to settle your system into the medicine rather than produce immediate weight loss) many people still feel conventional hunger, particularly a few hours after eating. That isn't the medicine failing; it's the medicine at its lowest point on the titration curve.

The pattern for most people is that appetite suppression becomes more consistent from around the 5mg or 7.5mg mark, though that varies considerably. If you're still in the early weeks, the honest answer is that some patience is built into how this medicine works. You can read more about the full picture of hunger on tirzepatide and what the timing typically looks like.

One misconception worth naming gently: a lot of people assume that if they still feel hungry, the medicine isn't working for them personally. That's rarely what the evidence shows. If you've been wondering why you feel hungry on Mounjaro, the reasons are usually tied to where you are in the titration process rather than anything going wrong with your treatment. Hunger and weight loss can move at different speeds, and the absence of dramatic appetite suppression early on doesn't predict how the treatment performs over months.

Why you might still feel hungry on tirzepatide even at a higher dose

Persistent hunger further into treatment, after you've titrated past the starter dose, tends to have more specific causes. Sleep is one that gets overlooked. A poor night raises ghrelin (the hormone most directly associated with appetite) and that effect can temporarily override tirzepatide's appetite signals. The medicine doesn't cancel ghrelin entirely; it works alongside your body's own hormonal environment, and a disrupted one can reassert itself. Stress has a similar mechanism through cortisol.

Meal composition matters too. Tirzepatide slows gastric emptying, which means food stays in your stomach longer than it otherwise would, but a meal that's mostly simple carbohydrates and low in protein empties faster and leaves less sustained satiety, even with the medicine on board. High-protein, high-fibre meals work with the slowed digestion rather than against it. If you're unsure how to structure eating alongside your treatment, our page on what to eat on Mounjaro covers the practical detail.

There's also the question of where you are in the weekly cycle. Some people notice that hunger edges back on day six or seven before their next injection, as the medicine's concentration falls slightly. This is a known pharmacokinetic pattern, not a sign of tolerance, and it's worth mentioning to your prescriber if it's consistent.

When hunger after a dose increase deserves a closer look

The first week after moving up a dose often feels different in both directions: some people experience more nausea, and a smaller group notices that hunger actually increases briefly before settling. This can feel contradictory. The likely explanation is that the body is adjusting to a new hormonal signal, and the adjustment period can briefly include appetite fluctuation alongside the GI effects the medicine is better known for.

According to the NHS tirzepatide information page, gastrointestinal effects are most common when starting the medicine or moving up a dose, and they usually settle. Appetite changes follow a similar trajectory, they stabilise, though the timeline differs from person to person.

If hunger remains a consistent problem well into a stable dose rather than just the adjustment window, that's the most useful thing to flag at your next clinical review. Persistent hunger at a maintained dose, rather than during transitions, can indicate that the dose isn't yet at the level where the medicine is working optimally for you, or that something in the wider picture (sleep, stress, meal timing) is counteracting it. The question of whether to titrate further is always a clinical one, made by a prescriber who knows your full history. For an overview of what supervised treatment looks like, the weight-loss treatment page explains the assessment process. The NICE appraisal of tirzepatide, TA1026, sets out the evidence base underpinning how and why this medicine is used in weight management.

What to do right now if hunger is making treatment feel difficult

A few practical steps are worth trying before assuming the medicine isn't working. Prioritise protein at every meal, it holds satiety longer than any other macronutrient, and it matters more on tirzepatide than off it because muscle preservation becomes important as weight falls. Fibre-rich vegetables slow digestion further and pair well with the medicine's own gastric-emptying effect. Staying hydrated helps too, because thirst and hunger share enough neurological territory that mild dehydration reads as appetite in a way that's easy to misread.

Timing matters. Eating at consistent intervals rather than waiting until hunger becomes urgent tends to reduce the overall intensity of appetite signals. If you're curious about broader questions around the experience of hunger on Mounjaro, there's more detail on what the research and clinical experience shows. And if you want to understand how tirzepatide compares to what hunger felt like before you started, the experience of still feeling hungry on tirzepatide is something a lot of people find reassuring to read about, it normalises what is, for most, a temporary phase rather than a permanent ceiling.

If you're not yet on treatment and wondering whether tirzepatide might suit you, you can check your eligibility through a free consultation with one of our GPhC-registered prescribers. A real clinician reads every submission the same day.